Thomas Mariani

Professor

University of Rochester
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (21)

Background Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) cause acute respiratory infections (ARI) in persons of all ages. The viruses are structurally similar although HMPV lacks 2 nonstructural proteins of RSV known to suppress interferon signaling. Methods We analyzed data from 2 studies that prospectively enrolled hospitalized adults with ARI and compared clinical characteristics and outcomes of HMPV and RSV infection. Gene expression was compared between subjects with HMPV and RSV using DESeq2 to analyze read counts from samples of globin-reduced RNA from whole blood, sequenced using Illumina NovaSeq. Results Of 1914 illnesses evaluated, 127 (6.6%) had RSV and 90 (4.7%) had HMPV identified as a sole viral pathogen. Demographics and preexisting conditions were similar although HMPV patients had significantly less active tobacco use and numerically less underlying heart and lung disease. Sore throat, temperature >38°C, and clinically adjudicated pneumonia were significantly more frequent with HMPV compared to RSV. Restricting analysis to those subjects adjudicated as viral alone without bacterial coinfection, we identified 197 differentially expressed genes between RSV- and HMPV-infected subjects. Genes with higher expression in HMPV-infected individuals were associated with antigen binding, immunoglobulin production, and adaptive immunity. Genes increased in RSV-infected individuals were associated with NK T cells. Conclusions Although RSV and HMPV are closely related viruses, we found differences in the clinical features of adults with HMPV patients presenting with more flu-like symptoms and viral pneumonia. Peripheral blood gene expression of hospitalized HMPV-infected patients also differed compared to those hospitalized and infected with RSV.

Year:

2025

Year:

2025

Respiratory tract infections (RTIs) are amongst the leading causes of hospitalizations in children with Down syndrome (DS). Their elevated susceptibility likely stems from structural differences in the airways and immune system abnormalities. The aim of this study was to characterize immune cells in prenatal Trisomy 21 (T21) lungs, potentially explaining vulnerability to RTIs. Single-cell RNA sequencing was used to profile immune cells in prenatal T21 (n = 5) and non-T21 (n = 4) prenatal lungs. Spatial phenotypes were assessed via fluorescent in situ hybridization and immunofluorescent staining on prenatal lung tissue sections. Gene expression analysis was also performed on isolated immune cells from lung single-cell suspensions. Several major immune cell populations were identified. A total of 84 DEGs were identified in at least 1 of the 14 different clusters. A significant decrease in the percentage of B cells was observed in T21 lungs (FDR = 0.0037, * p < 0.05). Furthermore, qRT-PCR demonstrated B cell markers were significantly decreased in T21, including those associated with B cell maturation (* p < 0.05 and ** p < 0.01). Several of these markers were also decreased at the protein level (i.e., CD20 and CD38; * p < 0.05 and ** p < 0.01). Our data demonstrate changes in the T21 pulmonary immune system in utero, primarily within the B cell population, which may contribute to the increased susceptibility to RTIs observed in children with DS.

Year:

2025

The lung is a vital organ that undergoes extensive morphological and functional changes during postnatal development. To disambiguate how different cell populations contribute to organ development, we performed proteomic and transcriptomic analyses of four sorted cell populations from the lung of human subjects 0–8 years of age with a focus on early life. The cell populations analyzed included epithelial, endothelial, mesenchymal, and immune cells. Our results revealed distinct molecular signatures for each of the sorted cell populations that enable the description of molecular shifts occurring in these populations during postnatal development. We confirmed that the proteome of the different cell populations was distinct regardless of age and identified functions specific to each population. We identified a series of cell population protein markers, including those located at the cell surface, that show differential expression and distribution on RNA in situ hybridization and immunofluorescence imaging. We validated the spatial distribution of alveolar type 1 and endothelial cell surface markers. Temporal analyses of the proteomes of the four populations revealed processes modulated during postnatal development and clarified the findings obtained from whole-tissue proteome studies. Finally, the proteome was compared with a transcriptomics survey performed on the same lung samples to evaluate processes under post-transcriptional control.

Year:

2025

Viral lower respiratory tract infections (LRTI) are ubiquitous in early life. They are disproportionately severe in infants and toddlers (0–2 years), leading to more than 100,000 hospitalizations in the United States per year. The recent relative resilience to severe Coronavirus disease (COVID‐19) observed in young children is surprising. These observations, taken together, underscore current knowledge gaps in the pathogenesis of viral lower respiratory tract diseases in young children and respiratory developmental immunology. Further, early‐life respiratory viral infections could have a lasting impact on lung development with potential life‐long pulmonary sequelae. Modern molecular methods, including high‐resolution spatial and single‐cell technologies, in concert with longitudinal observational studies beginning in the prenatal period and continuing into early childhood, promise to elucidate developmental pulmonary and immunophenotypes following early‐life viral infections and their impact on trajectories of future respiratory health. In November 2019, under the auspices of a multi‐disciplinary Workshop convened by the National Heart Lung Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, experts came together to highlight the challenges of respiratory viral infections, particularly in early childhood, and emphasize the knowledge gaps in immune, virological, developmental, and clinical factors that contribute to disease severity and long‐term pulmonary morbidity from viral LRTI in children. We hope that the scientific community will view these challenges in clinical care on pulmonary health trajectories and disease burden not as a window of susceptibility but as a window of opportunity.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Introduction The ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to evade antiviral immune signaling in the airway contributes to the severity of coronavirus disease 2019 (COVID-19). Additionally, COVID-19 is influenced by age and has more severe presentations in older individuals. Hence we investigate the role of innate immune signaling as a function of lung development and age. Method We investigated the transcriptome of the airway epithelium using pediatric and adult lung tissue samples from the LungMAP Human Tissue Core Biorepository. Specifically, lung lobes were digested and cultured into a biomimetic model of the airway epithelium on an air–liquid interface. Cells were then infected with SARS-CoV-2 and subjected to single-cell RNA sequencing. The data was analyzed using Seurat, scType, Monacle and tools to infer cell-cell communication. Results The clustering analysis identified following six cell populations: club cells, proliferating epithelial cells, multiciliated precursor cells, ionocytes, and two biologically distinct clusters of ciliated cells (FOXJ1high and FOXJ1low). Interestingly, the two ciliated cell clusters showed different infection rates and enrichment of processes involved in ciliary biogenesis and function; we observed a cell-type-specific suppression of innate immunity in infected cells from the FOXJ1low subset. We also identified a significant number of genes that were differentially expressed in lung cells derived from children as compared to adults, suggesting the differential pathogenesis of SARS-CoV-2 infection in children versus adults. Conclusion This work reveals age dependent differences in the lung epithelial cell response to SARS-CoV-2 infection. The results can be used to identify drug targets to modulate molecular signaling cascades that mediate an innate immune response.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (23)

Sangeeta Hingorani

Professor

University of Washington

UNITED STATES
View details

Song Feng

Assistant Professor

Baylor University

UNITED STATES
View details

Soula Danopoulos

Associate Professor

University of California, Los Angeles

UNITED STATES
View details

Zea Borok

Chair

UC San Diego Health System

UNITED STATES
View details

ANGELA BRANCHE

Associate Professor of Medicine

University of Rochester

UNITED STATES
View details

Ian Glass

Professor

University of Washington

UNITED STATES
View details

Denise Al Alam

Professor of Pediatrics

University of California, Los Angeles

UNITED STATES
View details

Bethany Moore

Professor

University of Michigan

UNITED STATES
View details

Hitesh Deshmukh

Associate Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

William Zacharias

Associate Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

Timothy S. Blackwell

Vanderbilt University Medical Center

UNITED STATES
View details

Maya I. Ragavan

-

UNITED STATES
View details

Megan N. Ballinger

The Ohio State University Wexner Medical Center

UNITED STATES
View details

Venkateshwar Keshamouni

University of Michigan

UNITED STATES
View details

Soumyaroop Bhattacharya

University of Rochester

UNITED STATES
View details

Ravi Misra

University of Rochester Medical Center

UNITED STATES
View details

David Keller

Professor/ Vice Chair of Clinical Strategy and Transformation

University of Denver

UNITED STATES
View details

Nicholas Jendzjowsky

Assistant Professor-in-Residence

UCLA Health

UNITED STATES
View details

Juilee Thakar

Associate Professor

University of Rochester

UNITED STATES
View details

Lisa Miller

Professor

University of California, Davis

UNITED STATES
View details

Henry Lee

University of California, San Diego

UNITED STATES
View details

Jeanne Holden-Wiltse

University of Rochester

UNITED STATES
View details

Gloria Pryhuber

Professor

University of Rochester Medical Center

UNITED STATES
View details